Centessa Pharmaceuticals plc (CNTA)

NGM – Real Time Price. Currency in USD

40.50

+40.50 (0.00%)

Market open: Jun 23, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

15M

Cost of goods sold

-923K

-942K

-813K

-131K

Gross Profit

14M

-942K

-131K

Operating expenses (excl. COGS)

-222M

-200M

-178M

-210M

Operating Income

-208M

-201M

-172M

-210M

Non-operating income, total

12M

-32M

-5M

-7M

Pretax income

-196M

-233M

-177M

-217M

Equity in earnings

Taxes

-2M

-3M

25M

747K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-198M

-236M

-152M

-216M

Discontinued operations

Net income

-198M

-236M

-152M

-216M

Dilution adjustment

Preferred dividends

Centessa Pharmaceuticals plc (CNTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Centessa Pharmaceuticals plc (CNTA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Centessa Pharmaceuticals plc (CNTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Centessa Pharmaceuticals plc (CNTA)

Income Statement (Annual)

Income Statement (Annual)